Nian-Nian Zhong

Dr. Nian-Nian Zhong


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2024 in International Journal of Surgery
Verified
Journal Article
Open access
YYYi-Fu Yu
Yi-Fu Yu
LCLei-Ming Cao
Lei-Ming Cao
ZLZi-Zhan Li
Zi-Zhan Li
NZNian-Nian Zhong
Nian-Nian Zhong
GWGuang-Rui Wang
Guang-Rui Wang
Lin-Lin BuLin-Lin Bu
Lin-Lin Bu
Background: Currently, neck dissection is a standard treatment for the majority of oral squamous cell carcinoma (OSCC) patients. However, the procedure can lead to a series of complications, significantly reducing patient quality of life and even affecting the antitumor immune response in patients undergoing immunotherapy. Therefore, in the era of precision surgery, gaining a deeper understanding of the patterns of lymph node metastasis (LNM) in OSCC is crucial. Materials and methods: Literature searches were performed on PubMed, Embase, Web of Science, Cochrane Library, WANFANGDATA, and China National Knowledge Infrastructure (CNKI) (inception to 10 April 2024). In addition, a manual searching was conducted in Scopus, Google Scholar, and Education Resources Information Center (ERIC). The authors included observational studies that evaluated the frequency of LNM in OSCC patients. Systematic review and a random effects model meta-analysis were performed. Results: The search identified 4694 articles, of which 17 studies included in our study. The authors calculated the frequency of LNM according to the data reported in the articles. Frequency of LNM=number of patients with positive lymph node / number of patients with OSCC. The frequency of LNM was 12% in level I (95% CI: 0.11–0.15, I 2 =38.01%), 20% in level II (95% CI: 0.17–0.22, I 2 =47.71%), 10% in level III (95% CI: 0.08–0.12, I 2 =49.10%), 2% in level IV (95% CI: 0.01–0.03, I 2 =27.58%), 1% in level V (95% CI: 0.00–0.01, I 2 =11.37%). Conclusion: The frequency of LNM is consistent with the ‘cascade theory’ and appears to be no significant difference from different primary sites. The frequency of LNM were low in levels I–III and were very low in level IV–V, which implicated that more conservative treatments may be considered for OSCC in the future. This study will help clinicians better determine the extent of surgery and preserve lymph nodes during neck dissection.

Verified
Journal Article
Open access
PDF file
LWLianhao Wang
Lianhao Wang
NZNian-Nian Zhong
Nian-Nian Zhong
XWXiaofeng Wang
Xiaofeng Wang
BPBoyuan Peng
Boyuan Peng
ZCZhuo Chen
Zhuo Chen
YCYong Cheng
Yong Cheng
Fibrosis commonly arises from salivary gland injuries induced by factors such as inflammation, ductal obstruction, radiation, aging, and autoimmunity, leading to glandular atrophy and functional impairment. However, effective treatments for these injuries remain elusive. Transforming growth factor-beta 1 (TGF-β1) is fundamental in fibrosis, advancing fibroblast differentiation into myofibroblasts and enhancing the extracellular matrix in the salivary gland. The involvement of the SMAD pathway and reactive oxygen species (ROS) in this context has been postulated. Metformin, a type 2 diabetes mellitus (T2DM) medication, has been noted for its potent anti-fibrotic effects. Through human samples, primary salivary gland fibroblasts, and a rat model, this study explored metformin’s anti-fibrotic properties. Elevated levels of TGF-β1 (p < 0.01) and alpha-smooth muscle actin (α-SMA) (p < 0.01) were observed in human sialadenitis samples. The analysis showed that metformin attenuates TGF-β1-induced fibrosis by inhibiting SMAD phosphorylation (p < 0.01) through adenosine 5′-monophosphate (AMP)-activated protein kinase (AMPK)-independent pathways and activating the AMPK pathway, consequently suppressing NADPH oxidase 4 (NOX4) (p < 0.01), a main ROS producer. Moreover, in rats, metformin not only reduced glandular fibrosis post-ductal ligation but also protected acinar cells from ligation-induced injuries, thereby normalizing the levels of aquaporin 5 (AQP5) (p < 0.05). Overall, this study underscores the potential of metformin as a promising therapeutic option for salivary gland fibrosis.

Verified
Journal Article
Open access
PDF file
JWJing Wang
Jing Wang
QMQi-Wen Man
Qi-Wen Man
NZNian-Nian Zhong
Nian-Nian Zhong
HWHanqi Wang
Hanqi Wang
CZChenxi Zhang
Chenxi Zhang
Bing LiuBing Liu
Bing Liu
Lymph node metastasis is associated with poor prognosis of oral squamous cell carcinoma (OSCC), and few studies have explored the relevance of postoperative lymphatic drainage (PLD) in metastatic OSCC. Alpha-enolase (ENO1) is a metabolic enzyme, which is related to lymphatic metastasis of OSCC. However, the role of ENO1 in PLD in metastatic OSCC has not been elucidated. Herein, we collected lymphatic drainage after lymphadenectomy between metastatic and non-metastatic lymph nodes in OSCC patients to investigate the relationship between ENO1 expression and metastasis, and to identify the proteins which interacted with ENO1 in PLD of patients with metastatic OSCC by MS/GST pulldown assay. Results revealed that the metabolic protein apolipoprotein C-III (ApoC3) was a novel partner of ENO1. The ENO1 bound to ApoC3 in OSCC cells and elicited the production of interleukin (IL)-8, as demonstrated through a cytokine antibody assay. We also studied the function of IL-8 on Jurkat T cells co-cultured with OSCC cells in vitro. Western blot analysis was applied to quantitate STAT3 (signal transducer and activator of transcription 3) and p-STAT3 levels. Mechanistically, OSCC cells activated the STAT3 signaling pathway on Jurkat T cells through IL-8 secretion, promoted apoptosis, and inhibited the proliferation of Jurkat T cells. Collectively, these findings illuminate the molecular mechanisms underlying the function of ENO1 in metastasis OSCC and provide new strategies for targeting ENO1 for OSCC treatment.

Verified
Journal Article
Open access
PDF file
JYJing-Rui Yi
Jing-Rui Yi
NZNian-Nian Zhong
Nian-Nian Zhong
XLXuan-Hao Liu
Xuan-Hao Liu
ZZZhengrui Zhu
Zhengrui Zhu
YZYi-Jia-Ning Zhang
Yi-Jia-Ning Zhang
Bing LiuBing Liu
Bing Liu
This study aims to investigate epithelial cell (EpC) heterogeneity in odontogenic keratocysts (OKCs) and the molecular mechanisms driving their characteristic keratinization and rapid proliferation. We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics to profile OKC EpCs, validating findings via immunostaining and comparative analysis with normal oral mucosa. The regulatory roles of interleukin-17 (IL-17) and the transcription factor EHF were functionally assessed in vitro using human oral keratinocytes. Multi-omics mapping identified a distinct epithelial subpopulation (EpC2) characterized by robust keratinization, elevated keratin 13 (KRT13), and upregulated IL-17 signaling. Clinical OKC tissues exhibited significant upregulation and spatial co-localization of IL-17 and KRT13. In vitro, IL-17 robustly promoted cellular proliferation and KRT13 expression. Regulon analysis pinpointed EHF as the core transcription factor driving EpC2. EHF knockdown suppressed proliferation and downregulated KRT13, while overexpression amplified these processes. Crucially, IL-17 stimulation failed to rescue KRT13 expression in EHF-depleted cells, suggesting EHF as a critical downstream mediator. We present a comprehensive single-cell and spatial transcriptomic atlas of the OKC epithelium. The IL-17/EHF signaling axis appears to be a fundamental driver of OKC pathogenesis, promoting pathological hyperkeratinization and cellular proliferation. Targeting this axis presents a promising therapeutic strategy to manage OKC growth and prevent recurrence.